In conclusion, our results have demonstrated that TJ001 inhibited cell growth in DU145 (p53 mutant) prostate cancer cells as indicated by blocking lipogenesis and induction in G1/S cell cycle arrest. This evidence concerns the gene TP53 and prostate cancer.